Insomnia is a common complaint in the geriatric population with studies indicating that 23-34% of elderly report symptoms of insomnia. Age-related changes in sleep physiology, diseases common in the elderly, and drug therapies common in the treatment of these diseases may result in difficulties with sleep. Managing these complaints requires a thorough evaluation to determine the etiology of insomnia since it is a symptom and not a disease. Additionally, when treating insomnia, non-pharmacologic issues need consideration before initiating drug therapy. A variety of pharmacologic agents are available to treat insomnia short term. Recently, two new novel agents have been added to the armamentarium of drugs that have some advantages over older, traditional agents.
Elie E, Eckart R, Fan I, et al.Sleep latency is shortened during 4 weeks of treatment with Zaleplon, a novel nonbenzodiazepine hypnotic. J Clin Psychiatry. 1999; 60:536-44.
2.
Foley DJ, Monjan AA, Brow SL, et al.Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep. 1995; 18:425-32.
3.
Bliwise DL.Sleep in normal aging and dementia. Sleep. 1993; 16(1): 40-81.
4.
National Institutes of Health Consensus Development Conference Statement.The treatment of sleep disorders of older people. Sleep. 1991; 14(2):169-77.
5.
Mullan E, Katona C, Bellew M.Patterns of sleep disorders and sedative hypnotic use in seniors. Drugs & Aging. 1994; 5(1):49-58.
6.
Marshall LL, Miller SW.Sleep disorders with aging. Clinical Consult. 1996; 11(suppl 8):1-9.
7.
Brezinova V.The number and duration of the episodes of the various EEG stages in young and older people. Electroencephalogic Clin Neurophysiol. 1975; 39:273-8.
8.
Zepelin H, Mcdonald CS, Zammit GK.Effects of age on auditory awakening thresholds. J Gerontol . 1984; 39:294-300.
9.
Ouchterlony D, Ham RJ , Marcy ML.Some common complaints of elderly. In Ham RJ (Ed). Primary care geriatrics: a case based learning program. 1987; pp. 259-78; Boston: PSG Publishing .
Kripke DF, Simons RN, Garfunkel L.Short and long sleep and sleeping pills: is increased mortality associated?Arch Gen Psychiatry. 1979; 36:103-16.
13.
Livingston G, Blizard B, Mann A.Does sleep disturbance predict depression in elderly people ? A study in inner London. Br J Gen Pract. 1993; 43:445-8.
14.
Gorbien MJ.When your older patient can't sleep; how to put insomnia to rest. Geriatrics . 1993; 48(9):65-75.
15.
Maczaj M.Pharmacological treatment of insomnia. Drugs. 1993; 45:44-55.
16.
Perrault G, Morel E, Sanger DJ, Zivkovic B.Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic Zolpidem. J Pharmacol Exp Ther. 1992; 263:298-303.
17.
Stimmel GL.Future directions in the drug treatment of insomnia. Psychiatry Times. 1999 Spring Suppl, pp. 1-8.
18.
Wagner J, Wagner ML, Hening WA.Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Am Pharmacother. 1998; 32:680-91.
19.
Rakel RE.Insomnia: concerns of the family physician. J Fam Pract. 1993 ; 36:551-58.
20.
Bachman DL.Sleep disorders with aging: evaluation and treatment. Geriatrics. 1992; 47(9): 53-61.
21.
Langtry HD, Benfield P.Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs . 1990; 40:291-313.
22.
Licciardello L, Licini P.Safety and efficacy of Zolpidem therapy in sleep disorders: a multicenter trial in hospitalized patients. Clin Ther Res. 1992; 52:652-8.
23.
Jonas JM, Coleman BS, Sheridan AQ, Kalinske RW.Comparative clinical profiles of triazolam versus other shorter-acting hypnotics. J Clin Psychiatr. 1992; 53(suppl 12):19-31.
24.
Evans SM, Funderburk FR, Griffiths RR.Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther. 1990; 255:1246-55.
25.
Beer B, Clody DE, Mangano R, et al.A review of the preclinical development of Zaleplon, a novel non-benzodiazepine hypnotic for the treatment of insomnia. CNS Drug Reviews . 1997; 3:207-24.
26.
Data on file, Wyeth-Ayerst Laboratories , Philadelphia, Pa.
27.
Danjan P, Paty I, Fruncillo R, et al.A comparison of the residual effects of Zaleplon and Zolpidem following administration 5 to 2 h. before awakening. Br J Clin Pharmacol . 1999; 48:367-74.
